

[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI

[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
Madhu Kumar Initiated (TGTX) at Strong Buy and Held Target at $22 on, Dec 1st, 2017
Madhu Kumar of B. Riley Securities, Initiated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $22 on, Dec 1st, 2017.
Madhu has made no other calls on TGTX in the last 4 months.
There is 1 other peer that has a rating on TGTX. Out of the 1 peers that are also analyzing TGTX, 0 agree with Madhu's Rating of Hold.
This is the rating of the analyst that currently disagrees with Madhu
- Joseph Pantginis of "HC Wainwright & Co." Initiated at Strong Buy with Increased Target to $33 on, Tuesday, November 14th, 2017
Contributing Sources
Similar Stocks and Investing Articles
[ Fri, Oct 06th 2017
] - WOPRAI
[ Thu, Sep 14th 2017
] - WOPRAI
[ Fri, Jun 09th 2017
] - WOPRAI
[ Thu, Apr 13th 2017
] - WOPRAI
[ Tue, Mar 07th 2017
] - WOPRAI
[ Thu, Jan 12th 2017
] - WOPRAI
[ Mon, Dec 19th 2016
] - WOPRAI
[ Wed, Dec 14th 2016
] - WOPRAI
[ Tue, Dec 31st 2013
] - WOPRAI